Risk factors for hepatotoxicity in patients hospitalized for tuberculosis


ERGAN B., Kirmizigul E., UZUN Ö., ÇÖPLÜ L.

EUROPEAN JOURNAL OF GENERAL MEDICINE, vol.14, no.1, pp.1-4, 2017 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 14 Issue: 1
  • Publication Date: 2017
  • Doi Number: 10.29333/ejgm/81870
  • Journal Name: EUROPEAN JOURNAL OF GENERAL MEDICINE
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CINAHL
  • Page Numbers: pp.1-4
  • Hacettepe University Affiliated: Yes

Abstract

Introduction: Combination therapy with four drugs (isoniazid, rifampicin, pyrazinamid and ethambutol) is the treatment of choice in tuberculosis but hepatotoxicity due to these drugs is an important medical concern. Therefore identification of patient groups with increased risk for antituberculosis therapy induced hepatotoxicity is crucial.